delta SUD PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
delta SUD PHARMA
Largest movements
- Receivables within one year -€31,192
down €31,192 (-24.2%), from €128,950 to €97,758
of which Other amounts receivable: -€47,132
- Tangible fixed assets -€19,934
down €19,934 (-9.8%), from €203,562 to €183,628
of which Other tangible fixed assets: -€19,523
- Cash +€5,872
up €5,872 (+13.6%), from €43,065 to €48,937
mainly Other debts (+€43,707) and Receivables within one year (+€31,192)
- Profit (loss) carried forward -€85,687
down €85,687 (-58.5%), from €146,584 to €60,897
- Other debts +€43,707
up €43,707 (+1,291%), from €3,385 to €47,092
- Trade debts -€14,663
down €14,663 (-12.9%), from €113,659 to €98,996
- Other operating charges -€8,655
down €8,655 (-32.5%), from €26,635 to €17,980
- Gross operating margin -€8,223
down €8,223 (-3.8%), from €216,642 to €208,418
- Financial charges -€4,649
down €4,649 (-26.9%), from €17,285 to €12,636
- Staff costs -€3,681
down €3,681 (-1.5%), from €238,135 to €234,454
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €529,988 | €477,640 | -€52,349 | -9.9% |
| Fixed assets | 21/28 | €226,747 | €203,589 | -€23,158 | -10.2% |
| Intangible fixed assets | 21 | €22,762 | €19,539 | -€3,224 | -14.2% |
| Tangible fixed assets | 22/27 | €203,562 | €183,628 | -€19,934 | -9.8% |
| Plant, machinery and equipment | 23 | €666 | €256 | -€411 | -61.6% |
| Furniture and vehicles | 24 | €0 | - | = | |
| Other tangible fixed assets | 26 | €202,896 | €183,373 | -€19,523 | -9.6% |
| Financial fixed assets | 28 | €422 | €422 | = | 0.0% |
| Current assets | 29/58 | €303,242 | €274,051 | -€29,191 | -9.6% |
| Stocks and contracts in progress | 3 | €127,315 | €123,654 | -€3,661 | -2.9% |
| Stocks | 30/36 | €127,315 | €123,654 | -€3,661 | -2.9% |
| Amounts receivable within one year | 40/41 | €128,950 | €97,758 | -€31,192 | -24.2% |
| Trade receivables | 40 | €76,901 | €92,840 | +€15,940 | +20.7% |
| Other amounts receivable | 41 | €52,050 | €4,918 | -€47,132 | -90.6% |
| Cash at bank and in hand | 54/58 | €43,065 | €48,937 | +€5,872 | +13.6% |
| Deferred charges and accrued income | 490/1 | €3,911 | €3,702 | -€209 | -5.3% |
| Total equity and liabilities | 10/49 | €529,988 | €477,640 | -€52,349 | -9.9% |
| Equity | 10/15 | €229,084 | €143,397 | -€85,687 | -37.4% |
| Contributions | 10/11 | €75,000 | €75,000 | = | 0.0% |
| Capital | 10 | €75,000 | €75,000 | = | 0.0% |
| Issued capital | 100 | €75,000 | €75,000 | = | 0.0% |
| Reserves | 13 | €7,500 | €7,500 | = | 0.0% |
| Non-distributable reserves | 130/1 | €7,500 | €7,500 | = | 0.0% |
| Legal reserve | 130 | €7,500 | €7,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €146,584 | €60,897 | -€85,687 | -58.5% |
| Amounts payable | 17/49 | €300,904 | €334,242 | +€33,339 | +11.1% |
| Amounts payable within one year | 42/48 | €281,454 | €311,605 | +€30,152 | +10.7% |
| Financial debts | 43 | €131,195 | €132,932 | +€1,737 | +1.3% |
| Credit institutions | 430/8 | €131,195 | €132,932 | +€1,737 | +1.3% |
| Trade debts | 44 | €113,659 | €98,996 | -€14,663 | -12.9% |
| Suppliers | 440/4 | €113,659 | €98,996 | -€14,663 | -12.9% |
| Taxes, remuneration and social security | 45 | €33,214 | €32,585 | -€629 | -1.9% |
| Taxes | 450/3 | €5,495 | €4,364 | -€1,130 | -20.6% |
| Remuneration and social security | 454/9 | €27,720 | €28,221 | +€501 | +1.8% |
| Other amounts payable | 47/48 | €3,385 | €47,092 | +€43,707 | +1,291% |
| Accrued charges and deferred income | 492/3 | €19,450 | €22,637 | +€3,187 | +16.4% |
| Non-recurring operating income | 76A | - | €23,954 | +€23,954 | |
| Remuneration, social security and pensions | 62 | €238,135 | €234,454 | -€3,681 | -1.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €29,665 | €28,108 | -€1,558 | -5.3% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €0 | €365 | +€365 | |
| Other operating charges | 640/8 | €26,635 | €17,980 | -€8,655 | -32.5% |
| Gross operating margin | 9900 | €216,642 | €208,418 | -€8,223 | -3.8% |
| Operating profit (loss) | 9901 | -€77,794 | -€72,488 | +€5,306 | +6.8% |
| Financial income | 75/76B | €73 | €135 | +€63 | +86.2% |
| Recurring financial income | 75 | €73 | €135 | +€63 | +86.2% |
| Financial charges | 65/66B | €17,285 | €12,636 | -€4,649 | -26.9% |
| Recurring financial charges | 65 | €17,285 | €12,636 | -€4,649 | -26.9% |
| Profit (loss) for the period before taxes | 9903 | -€95,006 | -€84,988 | +€10,018 | +10.5% |
| Income taxes | 67/77 | €593 | €699 | +€106 | +17.8% |
| Profit (loss) for the period | 9904 | -€95,599 | -€85,687 | +€9,912 | +10.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€95,599 | -€85,687 | +€9,912 | +10.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.